DUBLIN, Calif., May 12 /PRNewswire-FirstCall/ -- SuperGen, Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the Rodman & Renshaw 5th Annual Global Healthcare Conference on May 19, 2008 at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
SuperGen's presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference is scheduled to begin at 11:05 a.m. Central Europe Time (5:05 a.m. Eastern Daylight Time). A live webcast of the presentation will be available on the investor relations section of the Company's Web site at http://www.supergen.com/. The webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com/.
Contacts
Timothy L. Enns Mary M. Vegh
SuperGen, Inc. SuperGen, Inc.
SVP, Corporate Communications & Business Manager, Investor
Development Relations
Tel: (925) 560-0100 Tel: (925) 560-2845
E-mail: tenns@supergen.com E-mail: mary.vegh@supergen.com
Copyright 2008 PR Newswire. All Rights Reserved